Publicaciones en las que colabora con EMILIO ESTEBAN GONZALEZ (12)

2012

  1. Predictive factors for response to treatment in patients with advanced renal cell carcinoma

    Investigational New Drugs, Vol. 30, Núm. 6, pp. 2443-2449

  2. Prognostic factors in patients with advanced renal cell carcinoma

    Clinical Genitourinary Cancer, Vol. 10, Núm. 4, pp. 262-270

2010

  1. Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: Study based on experience at the Hospital Universitario Central de Asturias

    Clinical and Translational Oncology, Vol. 12, Núm. 8, pp. 562-567

2009

  1. Impact of Tyrosine Kinase Inhibitors (TKIs) in the treatment of patients with advanced renal cell carcinoma (RCC): A single centre retrospective review at the Hospital Universitario Central de Asturias

    EJC SUPPLEMENTS

2007

  1. Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): Results of a prospective randomized study

    Lung Cancer, Vol. 55, Núm. 2, pp. 173-180

  2. Estudio retrospectivo en pacientes con diagnóstico de carcinoma de pulmón no microcítico estadio avanzado tratados con la combinación gemcitabina y vinorelbina: Valoración de la eficacia terapéutica y factores pronósticos

    Oncologia, Vol. 30, Núm. 2, pp. 32-43

2006

  1. Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

    Investigational New Drugs, Vol. 24, Núm. 3, pp. 241-248

2003

  1. Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: A dose-finding study

    Breast Cancer Research and Treatment, Vol. 80, Núm. 3, pp. 257-265

  2. Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

    Annals of Oncology, Vol. 14, Núm. 11, pp. 1640-1647

2002

  1. Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer

    Investigational New Drugs, Vol. 20, Núm. 3, pp. 317-326

  2. Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer

    Investigational New Drugs, Vol. 20, Núm. 1, pp. 73-82

1999

  1. Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

    Breast Cancer Research and Treatment, Vol. 58, Núm. 2, pp. 141-150